Objective: Respiratory allergy to laboratory animals is a common and preventable occupational health problem. This study documents current laboratory animal allergy (LAA) prevention programs in the United States. Methods: An online survey was e-mailed to designated institutional officials at laboratory animal facilities identified by the National Institutes of Health Office of Laboratory Animal Welfare. Results: A total of 198 organizations responded and more than 80% required the use of uniforms and gloves to control exposure. Respirators were required by 25% of organizations. Medical surveillance was mandated by 58% of organizations (70% for organizations with at least 100 employees working with animals). Work restriction practices varied. Only 25% of organizations reported knowing the prevalence (range: 0% to 75%) and 29% reported knowing the incidence of LAA (range: 0% to 18%). Conclusions: There is broad variation in policy and practice to prevent LAA. An evidence-based consensus would ensure greater protection of workers.
L aboratory animal allergy (LAA) is a serious occupational hazard for workers in research laboratories that can affect health and career options. Respiratory allergy and asthma is of the greatest concern because it is common and requires a multifaceted prevention strategy. Manifestations of respiratory allergy include allergic conjunctivitis, rhinitis, and asthma. Prevention of animal allergy depends on the control of allergenic material in the work environment. Exposure varies by job and tasks as well as various workplace factors. 1, 2 Personal protective equipment (PPE) and air-purifying respirators are recommended when exposure cannot be adequately controlled using engineering control technologies, administrative controls, and work practice controls. Occupational medicine specialists play a critical role in these programs including medical surveillance, diagnosis of LAA, and determining work restrictions for workers with allergy and asthma. The objective of this study is to document current LAA prevention and control programs in animal laboratory facilities in the United States.
METHODS
An online survey (SurveyMonkey) was e-mailed to the designated institutional official at all laboratory animal care facilities identified by the National Institutes of Health Office of Laboratory Animal Welfare (1033 facilities across the country). Supplemental requests to encourage completion of the survey were distributed through the American College of Occupational and Environmental Medicine Pharmaceutical Industry Section, the Pharmaceutical Safety Group, and the Campus Safety Health and Environmental Management Association. Survey responses were collected and analyzed. The survey included questions on the following:
1. the total number of employees exposed to laboratory animal allergens in each facility, 2. administrative controls, 3. engineering controls, 4. the use and availability of PPE including clothing and respirators, 5. recommended hygiene practices for employees, 6. medical surveillance for LAA, 7. criteria for LAA diagnosis, 8. the prevalence and incidence of LAA at each facility, and 9. work restrictions recommended for LAA diagnosed workers.
The study protocol was approved by the Duke University institutional review board.
RESULTS
Surveys were sent to 1033 organizations identified by the National Institutes of Health Office of Laboratory Animal Welfare and 83 of them were returned as undeliverable. Responses were received from 198 institutions (19.2% overall response rate).
Most (69%) responding organizations were classified as university/academic/medical center (Table 1) . Research institutes comprised 15.2% of respondents. Pharmaceutical organizations were well represented with 14 companies. The remaining respondents include other commercial or other types of organizations.
The number of employees working with laboratory animals at responding institutions ranged from 1 to 4000. Almost 40% of these institutions had between 15 and 99 employees conducting animal work, whereas 25% had between 100 and 499. One fifth of responding institutions had more than 500 employees handling animals (Table 2) .
Exposure Control

Administrative Controls
In almost all workplaces, work with animals is conducted in a dedicated animal facility. However, 65% of organizations also conduct work outside of dedicated facilities where animals are housed.
Access to animal rooms is restricted by 92% of employers. Eighty percent of employers restrict used (contaminated) PPE to the animal facility, 48% have separate lockers for clean clothes, and 20% of respondents require employees to shower out. Training of workers on the prevention of LAA was reported by 82% of employers (Table 3) .
Work Practice Controls
Hand washing is the most common work practice control used by 96% of employers. Of these, two thirds limit animal density and two thirds use room-cleaning procedures that minimize exposures such as high efficiency particulate air (HEPA) filtered vacuums and a wet process. Fifty-five percent of employers use work process design to limit animal handling. Wet prep is used for shaving by 20% of employers (Table 4) . 
Personal Protective Equipment
There is great variation in the mandated use of PPE (Table 6 ). At least one sixth of programs mandate the use of at least an N95 air-purifying respirator and overall 25% of respondents mandate the use of respirator for all tasks. More than 40% of respondents mandate the use of surgical masks. The masks do not function as respirators, although they can provide some protection from infection for the animals. The survey did not differentiate on the possible reasons for use. The most common forms of PPE used are gloves and uniforms/clothing covers (more than 80%).
Most organizations make various forms of PPE available to employees when it is not required ( Table 7) . More than 80% of organizations offer respirators to employees on a mandatory or voluntary basis.
Employers mandate various PPE for specific tasks (Table 8) . Cage cleaning is known to generate high levels of airborne allergens and has the greatest requirements. The use of hair covers is relatively low (except for cage cleaning), despite data showing that they protect against the carriage of allergens. 
Medical Surveillance
Preplacement assessments are conducted by three fourths of respondents. Medical surveillance is conducted for at least some employees by 85% of institutions. However, only 58% of institutions make medical surveillance mandatory for all and 14% also mandate medical surveillance for some employees (Table 9 ). Of those institutions conducting medical surveillance, 91% incorporate questionnaires and 52% include a clinical examination (Table 10) . At some institutions, a clinical assessment was performed dependent on responses to a questionnaire.
A minority of respondents conducted additional testing routinely. This includes pulmonary function testing that in some cases is conducted for respirator clearance. Skin prick tests are performed by 8% and radioallergosorbent test (RAST) is reported by 6% of institutions.
Organizations with larger animal handling workforces are more likely to conduct medical surveillance (Figure 1 ). Mandatory medical surveillance ranges from about 40% for employers with fewer than 15 employees working with animals to more than 70% for those with at least 100 animal workers. The type of organization had limited effect on whether medical surveillance was mandatory (Fig. 2) .
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Medical surveillance findings are reviewed with employees by almost all organizations conducting medical surveillance. Only 7% of these organizations perform an analysis of group data. 
Work Restrictions
A slight majority of employers will consider excluding workers with non-asthma LAA from continued work with animals depending on the severity of the allergy (Table 11) . One third of employers allow allergic workers to continue working with restrictions. None of the organizations exclude allergic workers from animal work, although some will exclude workers from handling the type of animal that they are allergic to.
For workers that develop LAA asthma, 10% of organizations exclude them from continued animal work, whereas 5% do not write any restrictions (Table 12) . One eighth of organizations exclude continued work with the problematic species and slightly more than three fifths consider exclusion depending on the severity of asthma.
Prevalence and Incidence of Laboratory Animal Allergy
Almost 90% of respondents based their definition of respiratory LAA on self-reported symptoms (Table 13 ). However, most organizations supplemented their diagnosis with clinical assessments and many also utilized testing (RAST or skin prick testing).
Most respondents did not know the prevalence or incidence of LAA for their organizations. Twenty-five percent of respondents reported knowledge of LAA prevalence, whereas 29% were aware of the incidence of LAA (Figure 3 ). Reported awareness of prevalence and incidence was the lowest among employers with 100 to 499 employees working with animals, despite the higher rate of medical surveillance in this group. Knowledge of prevalence and incidence was the lowest in the university/academic/medical center setting (Fig. 4) . Pharmaceutical industry respondents indicated the highest awareness of prevalence (36%) and 43% of non-pharmaceutical commercial organizations reported knowing the incidence rate.
Among organizations that said the data were available, the reported prevalence rate ranged from 0% to 75% and the 1-year incidence rate ranged from 0% to 18%. Of these, 18 organizations reported a prevalence of 0%. Some respondents indicated that they were aware of prevalence or incidence rates, but not both. Of those responding that the incidence rate was available, 37 reported an incidence of 0%. However, the survey did not query how these rates were determined. Among the organizations reporting a 1-year incidence rate of 3% or less, only 36% reported conducting mandatory medical surveillance. Most organizations that reported incidence data were available did not conduct mandatory medical surveillance.
DISCUSSION
Laboratory animal allergy remains a significant occupational health issue. There have been very few published studies describing the effects of prevention practices on the prevalence and incidence of LAA. This study represents the first US national survey of LAA prevention practices. This study reveals that there is a wide range of practices and no consistent approach to the prevention of LAA. Although some variation would be anticipated on the basis of differences in facility design and other factors, it is likely that many of the differences in approach, policy, and practice are based on individual and institutional preferences. Variation in practice may also be based on perceived success in controlling exposure.
Methods to control exposure were reviewed by Harrison. 4 Krop et al 3 have demonstrated the importance of using hair-covering caps. Schweitzer et al 5 have also shown that housing mice in ventilated cages operated under negative pressure and using ventilated changing tables reduced ambient mouse allergen (Mus m 1) concentrations tenfold, compared with the use of conventional caging and a non-ventilated changing table. Ambient allergen was not reduced when mice were housed in positively pressurized cages versus conventional cages, or when animal rooms were cleaned more frequently.
Most organizations report using a combination of engineering, administrative, work practice controls along with PPE. However, even when looking at PPE required for specific tasks, there is no consensus approach among respondents.
To determine the effectiveness of LAA prevention programs, knowledge of the prevalence and incidence of primary and secondary LAA is critical. Active medical surveillance is more likely to identify all incident cases than passive surveillance (relying on workers' reporting). However, more than 40% of respondents did not mandate medical surveillance. Nicholson et al 6 reviewed 109 studies to determine the evidence base for medical surveillance. They recommended a baseline health assessment and periodic medical surveillance. Medical surveillance was also reviewed by Seward.
7 Prototype LAA questionnaires for initial and follow-up surveillance have been published. 8 Although most respondents did not know the prevalence or incidence of LAA, many that did report rates reported very low rates or rates of zero. Given the background prevalence in the literature of 14% to 44%, 9 the finding that a large number of programs reported such low prevalence rates was unexpected. A review of 15 cross-sectional studies and 4 longitudinal studies by Folletti et al 10 suggested a decrease in the prevalence of occupational asthma, but not occupational allergy from 1980 to 2006. That review is limited to the published literature and represents only a small minority of laboratory animal worksites. It is possible that prevalence rates have in fact fallen or that workers with LAA are choosing not to seek jobs working with animals. Another possibility is that workers with LAA are being excluded from employment, but this seems unlikely as most respondents indicated that workers with LAA could usually continue their work. Another hypothesis is that the reports are based on the lack of awareness, especially in organizations that do not conduct medical surveillance, or do not analyze surveillance results for all workers, or both. Group surveillance was uncommon, reported by only 7% of organizations. Similar issues surround the reporting of incidence rates. There is only one program in the published literature that described a comprehensive LAA prevention program that was able to reduce the incidence of LAA to zero. 11 Other programs that have been able to prevent LAA are encouraged to publish their prevention programs to expand understanding of factors critical to successful prevention.
More than 10% of organizations incorporate testing (RAST or skin prick testing) into medical surveillance and a larger number utilize testing to help define a case of LAA. When using RAST for medical surveillance, positive results may not correlate with symptoms. Matsui et al 12 have shown that among workers with detectable mouse IgE, higher mouse IgG and mouse IgG4 levels are associated with a decreased risk of mouse-related symptoms and may be markers for clinical tolerance. In comparing tests, Sharma et al 13 reported that skin prick testing performs "best in discriminating patients with and without mouse allergy." However skin prick testing requires special training, which may necessitate referral.
This study has several limitations. The response rate was good for a survey distributed by e-mail; however, slightly less than 20% of institutions responded, raising questions about generalizability. Those responding include a large number of diverse organizations and likely represent the breadth of current practices, even if the actual percentages might differ. As the survey is based on self-report, the responses may not accurately reflect full knowledge of institutional practices.
To keep the questionnaire short, a number of topics were not explored. These include data on the use of industrial hygiene sampling to monitor exposure and approaches to the prevention of secondary LAA (allergy to additional species after developing LAA to one species), which can develop in settings that protect against the development of primary LAA.
The variability in practices described in the survey responses indicates the need for an evidence-based consensus effort to define the essential elements of a successful prevention effort. To support this effort, there is a need for more organizations to publish descriptions of their LAA programs and experience.
